Protagonist Therapeutics (PTGX) Other Non-Current Assets (2015 - 2026)
Protagonist Therapeutics (PTGX) posted Other Non-Current Assets of $288000.0 for Q1 2026, little changed sequentially from $287000.0 in Q4 2025, and up 28.0% YoY from $225000.0 in Q1 2025.
Protagonist Therapeutics (PTGX) Other Non-Current Assets (2015 - 2026) Analysis & Trends
Protagonist Therapeutics has reported Other Non-Current Assets for 12 years, with the latest figure at $288000.0 in Q1 2026.
- Quarterly Other Non-Current Assets rose 28.0% year-over-year to $288000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $288000.0 (up 28.0% YoY) and the FY2025 annual result came in at $287000.0, up 27.56% from the prior year.
- Other Non-Current Assets held at $288000.0 in Q1 2026 per PTGX's latest filing, from $287000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $290000.0 in Q2 2025 and troughed at $225000.0 in Q1 2022.
- A 5-year average of $239823.5 and a median of $225000.0 in 2022 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets changed 0.0% in 2022, then gained 28.89% in 2025.
- Over 5 years, Other Non-Current Assets stood at $225000.0 in 2022, then changed by 0.0% to $225000.0 in 2023, then changed by 0.0% to $225000.0 in 2024, then grew by 27.56% to $287000.0 in 2025, then advanced by 0.35% to $288000.0 in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $288000.0, $287000.0, and $287000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Protagonist Therapeutics | 10.03 Bn | 10.03 Bn | - | 832,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 832,000.00 |
| Mar 31, 2026 | 288,000.00 |
| Dec 31, 2025 | 287,000.00 |
| Sep 30, 2025 | 287,000.00 |
| Jun 30, 2025 | 290,000.00 |
| Mar 31, 2025 | 225,000.00 |
| Dec 31, 2024 | 225,000.00 |
| Sep 30, 2024 | 225,000.00 |
| Jun 30, 2024 | 225,000.00 |
| Mar 31, 2024 | 225,000.00 |
| Dec 31, 2023 | 225,000.00 |
| Sep 30, 2023 | 225,000.00 |
| Jun 30, 2023 | 225,000.00 |
| Mar 31, 2023 | 225,000.00 |
| Dec 31, 2022 | 225,000.00 |
| Sep 30, 2022 | 225,000.00 |
| Jun 30, 2022 | 225,000.00 |
| Mar 31, 2022 | 225,000.00 |
| Dec 31, 2021 | 225,000.00 |
| Sep 30, 2021 | 225,000.00 |